Arrowhead Pharmaceuticals Inc (ARWR)

Return on equity (ROE)

Sep 30, 2025 Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net income US$ in thousands -1,631 -599,493 -205,275 -176,494 -140,848
Total stockholders’ equity US$ in thousands 466,052 185,444 271,343 398,520 408,822
ROE -0.35% -323.27% -75.65% -44.29% -34.45%

September 30, 2025 calculation

ROE = Net income ÷ Total stockholders’ equity
= $-1,631K ÷ $466,052K
= -0.35%